What This Document Is
This document is a historical and procedural overview of the Kirby-Bauer disk diffusion susceptibility test—a widely used method in microbiology to determine the effectiveness of antimicrobial drugs against specific bacteria. It details the evolution of this testing method, from early broth dilution techniques to the standardized protocol used in modern clinical laboratories.
Why This Document Matters
This protocol is essential for microbiology professionals, researchers, and students involved in clinical diagnostics and antimicrobial stewardship. It’s used whenever a physician needs to determine the best antibiotic to treat a bacterial infection, ensuring effective treatment and minimizing the development of antibiotic resistance. Understanding the history and standardization of this test is crucial for accurate interpretation of results and reliable patient care.
Common Limitations or Challenges
This document provides the foundational understanding of the Kirby-Bauer test, but it does not replace the need for current Clinical & Laboratory Standards Institute (CLSI) guidelines. Antimicrobial resistance patterns are constantly evolving, requiring ongoing updates to interpretative criteria. This document also doesn’t cover advanced susceptibility testing methods or specific quality control procedures.
What This Document Provides
The full document includes: a detailed history of antimicrobial susceptibility testing, tracing its development from Fleming’s discovery of penicillin; an explanation of the standardization efforts led by Kirby and Bauer and the subsequent role of the CLSI; and a clear statement of the test’s purpose – to guide antibiotic selection for patient treatment. This preview *does not* include the specific procedures for performing the test, interpreting zone sizes, or detailed quality control measures. It also does not contain the latest CLSI guidelines or specific antimicrobial breakpoints.
